Trending: Philips in Final Agreement With DOJ, FDA on Ventilators
1411 ET -- Philips is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The company reached a final agreement with the U.S. Justice Department and Food and Drug Administration on a settlement related to Respironics ventilators. According to the DOJ, Philips is required to stop manufacturing most sleep and respiratory devices at three Pennsylvania facilities until it takes specific measures. The company discussed its progress, including working with the FDA, and said "we now have a clear path forward to gradually restore the business, serving patients around the world." Dow Jones & Co. owns Factiva. (josh.beckerman@wsj.com)
(END) Dow Jones Newswires
April 10, 2024 14:27 ET (18:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Should You Buy and Hold an Artificial Intelligence Portfolio?
-
3 Cheap and Dependable Dividend-Growth Stocks to Buy
-
The Best Bank Stocks to Buy
-
After Earnings, Is Roblox Stock a Buy, Sell, or Fairly Valued?
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?